Skip to main content
Equibles

EVAX · Evaxion A/S

Track EVAX — free

Use EVAX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EVAX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.15 -0.05 (-1.56%) At close · Oct 5
Rebalance outlook locked
Market Cap
$28.42M
Shares
9.02M
Volume · Oct 5 38.25K Avg daily vol (3M) 198.77K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$3.20 Open$3.23 Day$3.16–3.28 52W close$2.79–11.01 Avg vol 30d77K Short int54K · 0.6% float · 1.2d Short vol49% Last earningsAug 20, 2026 DataFeb 2021–Oct 2026

Up next

Next earnings call
Nov 19, 2026 Est · unconfirmed · in 6 wks
Q2 2026 earnings call transcript
call held Aug 20, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-32.5%
Trailing year
Short interest
0.6%
Latest settlement · 1.2 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Bullish Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.3 · calm Equity put/call 0.59
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −13%
below
Price vs 50-day avg +3%
above
RSI (14) 50
neutral
MACD trend Negative
52-week position 5%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +4%
trailing
6-month return −23%
trailing
YTD return −33%
this year
Relative strength −35%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow Accumulating
+12% holders QoQ · +3 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.60% of float · ▼ -4.8% MoM · 1.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
19 holders — near 3-yr high, broad support
Squeeze score 52
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 102%
annualized · 1-yr
Max drawdown −75%
past year
ATR 4.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Mar 31, 2026
Operational cash burn · 2026 $14M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−13% Bearish
Price vs 50-day avg
+3% Bullish
RSI (14)
50 Neutral
MACD trend
Negative Bearish
52-week position
5% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow Accumulating
+12% holders QoQ · +3 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.60% of float · ▼ -4.8% MoM · 1.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
19 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $3 Now $3 · 5% Range high $11
vs 200-day avg -13% vs 50-day avg +3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
EVAX
Evaxion A/S
this stock
$28.42M -32.9% — — 0.6%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $133.37B +11.3% +46.2% 30.7 1.9%
REGN
Regeneron Pharmaceuticals, Inc.
 $81.13B -4.8% +20.8% 19.5 2.5%
MRNA
Moderna, Inc.
 $79.40B +544.3% +4.3% — 8.2%
CSLLY
Csl Ltd
 $61.25B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
19
% held
17.6%
Net QoQ
+48.8K sh
Top holder
Merck & Co., Inc.
Held Float
View
Held by Funds
Fund positions
1
View
Short & Settlement
Short Interest Falling
Shares short
53.8K
Days to cover
1.2d
Change
-2.7K sh
View
Short Volume
Short vol %
49%
As of
Oct 5, 2026
Short Total
View
Fails to Deliver
FTD shares
128
Value
$393
As of
Sep 3, 2026
View
Off-Exchange
Off-exchange %
44.8%
Week of
Aug 31, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 2, 2026
This year
32
View
Earnings & Events
Webcasts
Last webcast
Aug 20, 2026
View
Investor Relations
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
EVAX -4.2% +3.9% -22.7% -2.4% -32.9%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY -4.0% +4.4% -34.9% -3.4% -45.8%
Key facts CIK 1828253 CUSIP 29970R303 Visit website Investor relations